Efficacy of Listerine Antiseptic in reducing viral contamination of saliva
- PMID: 15811049
- PMCID: PMC7166778
- DOI: 10.1111/j.1600-051X.2005.00673.x
Efficacy of Listerine Antiseptic in reducing viral contamination of saliva
Abstract
Aim: The anti-viral efficacy of oral antimicrobial rinses has not been adequately studied in terms of potential clinical significance. As a follow-up to an in vitro study on the effect of oral antiseptics on Herpes simplex virus, Type 1, this study was undertaken to evaluate the in vivo effect of an essential oil containing oral antiseptic on the reduction of viral titer in saliva during active viral infection.
Method: Patients were recruited and evaluated in a single visit protocol at the onset of a perioral outbreak, consistent historically and clinically with recurrent Herpes labialis. Direct immunofluorescence of cytological smears of the lesions/oral fluids was used to confirm Herpes simplex virus types I or II. Patients were randomly assigned to one of two treatment groups: (1) active ingredient and (2) sterile water control. The viral lesion was evaluated as to clinical stage according to standard protocol. Salivary fluid samples were taken: (1) at baseline; (2) immediately following a 30 s rinse; (3) 30 min. after the 30 s rinse; and (4) on the repeat trial, also at 60 min. after the 30 s rinse. All samples were evaluated for viral titer and results compared.
Results: In Trial 1, the sample population consisted of 19 males and 21 females with an average age of 29.2 and in Trial 2, 21 males, 19 females with an average age of 28. In both Trials 1 and 2, recoverable infectious virions were reduced to zero after a 30 s experimental rinse; whereas, the control rinse resulted in a non-significant (p>0.05) reduction. The experimental group also demonstrated a continued significant (p<0.05) reduction 30 min. post rinse when compared with baseline while the control group returned to baseline levels. In Trial 2, the 60 min. post rinse follow-up demonstrated a 1-2 log residual reduction from baseline in the experimental group; however, this was not significant.
Conclusions: There is clinical efficacy in utilizing an oral rinse with the antimicrobial agent Listerine Antiseptic in reducing the presence of viral contamination in oral fluids for at least 30 min. after oral rinse. The risk of viral cross contamination generated from these oral fluids in person to person contact or during dental treatment may be reduced.
Figures
Similar articles
-
Oral antiseptics against coronavirus: in-vitro and clinical evidence.J Hosp Infect. 2021 Jul;113:30-43. doi: 10.1016/j.jhin.2021.04.004. Epub 2021 Apr 15. J Hosp Infect. 2021. PMID: 33865974 Free PMC article. Review.
-
Effect of an essential oil-containing antiseptic mouthrinse on plaque and salivary Streptococcus mutans levels.J Clin Periodontol. 2000 Mar;27(3):157-61. doi: 10.1034/j.1600-051x.2000.027003157.x. J Clin Periodontol. 2000. PMID: 10743861 Clinical Trial.
-
The efficacy of antimicrobial mouth rinses in oral health care.Bull Tokyo Dent Coll. 1998 Feb;39(1):7-14. Bull Tokyo Dent Coll. 1998. PMID: 9663026 Review.
-
Bactericidal effects of mouth rinses on oral bacteria.Bull Tokyo Dent Coll. 1997 Nov;38(4):297-302. Bull Tokyo Dent Coll. 1997. PMID: 9566143
-
Effect of an antiseptic mouthrinse on salivary microbiota.Am J Dent. 1996 Jun;9(3):93-5. Am J Dent. 1996. PMID: 9002796 Clinical Trial.
Cited by
-
Administration of Clinical COVID-19 Mouthwashing Protocol and Potential Modulation of Pediatric Oral Bacterial Prevalence of Selenomonas noxia: A Pilot Study.Pediatr Rep. 2023 Jul 11;15(3):414-425. doi: 10.3390/pediatric15030038. Pediatr Rep. 2023. PMID: 37489412 Free PMC article.
-
Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.BMC Oral Health. 2023 Jul 3;23(1):443. doi: 10.1186/s12903-023-03126-4. BMC Oral Health. 2023. PMID: 37400836 Free PMC article.
-
Preprocedural mouthwashes for infection control in dentistry-an update.Clin Oral Investig. 2023 Jun;27(Suppl 1):33-44. doi: 10.1007/s00784-023-04953-z. Epub 2023 Apr 20. Clin Oral Investig. 2023. PMID: 37079156 Free PMC article. Review.
-
Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.J Med Virol. 2023 Jan;95(1):e28412. doi: 10.1002/jmv.28412. J Med Virol. 2023. PMID: 36527332 Free PMC article. Clinical Trial.
-
The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses.J Lipid Res. 2022 Jun;63(6):100208. doi: 10.1016/j.jlr.2022.100208. Epub 2022 Apr 15. J Lipid Res. 2022. PMID: 35436499 Free PMC article.
References
-
- Arvin, A. M. & Prober, C. G. (1999) Herpes simplex viruses In: Manual of Clinical Microbiology, (eds). Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C. & Yolken R. H. pp. 878–887. Washington, DC: SM Press.
-
- Baqui, A. A. M. A. , Kelley, J. I. , Jabra‐Rizk, M. A. , DePaola, L. G. , Falkler, W. A. & Meiller, T. F. (2001) In vitro effect of oral antiseptics on human immunodeficiency virus‐1 and Herpes simplex virus type 1. Journal of Clinical Periodontology 28, 610–616. - PubMed
-
- Bernstein, D. , Schiff, G. , Echler, G. , Prince, A. , Feller, M. & Briner, W. (1989) In vitro virucidal effectiveness of a 0.12% chlorhexidine gluconate mouthrinse. Journal of Dental Research 69, 874–876. - PubMed
-
- Crane, L. R. , Gutterman, P. A. , Chapel, T. & Lerner, A. M. (1980) Incubation of swab materials with Herpes simplex virus. Journal of Infectious Diseases 141, 531–534. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials